









Markets
/
Stocks
/
nasdaq-iinn
/

Inspira Technologies Oxy BHN Ltd

IINN

1.240USD

-0.010-0.80%

Close 09/19, 16:00（ET）Quotes delayed by 15 min

30.07MMarket Cap

LossP/E TTM



Inspira Technologies Oxy BHN Ltd

1.240

-0.010-0.80%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

141 / 207

Overall Ranking

397 / 4720

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 1 analysts

Buy

Current Rating

3.000

Target Price

+140.00%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Inspira Technologies Oxy B.H.N Ltd, formerly Insense Medical Ltd, incorporated on February 27, 2018, is a specialty medical device company based in Israel. The Company is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). It provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV.

Fairly Valued

The company’s latest PE is -2.08, at a medium 3-year percentile range.

Institutional Buying

The latest institutional holdings are 3.57M shares, increasing 34.13% quarter-over-quarter.

Held by James Simons

Star Investor James Simons holds 0.00 shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.50.

Financial Health

Currency: USD Updated: 2025-09-19

There is no financial score for this company; the Healthcare Equipment & Supplies industry's average is 7.32.

Score

Industry at a Glance

Previous score

0.00

Change



Financials



Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings



Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency



Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential



Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns



Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated: 2025-09-19

The company’s current valuation score is 2.80, which is lower than the Healthcare Equipment & Supplies industry's average of 3.59. Its current P/E ratio is -2.09, which is -9.60% below the recent high of -1.89 and -12.00% above the recent low of -2.35.

Score

Industry at a Glance

Previous score

2.80

Change

1.2

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 141/207

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-19

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.70. The average price target for Inspira Technologies Oxy BHN Ltd is 3.00, with a high of 3.00 and a low of 3.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 1 analysts

Buy

Current Rating

3.000

Target Price

+140.00%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Inspira Technologies Oxy BHN Ltd

IINN

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Intuitive Surgical Inc

ISRG

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-19

The company’s current price momentum score is 6.83, which is higher than the Healthcare Equipment & Supplies industry's average of 6.80. Sideways: Currently, the stock price is trading between the resistance level at 1.39 and the support level at 1.11, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.83

Change

-0.06

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(2)

Buy(4)

Indicators

Value

Direction

MACD(12,26,9)

0.011

Neutral

RSI(14)

53.628

Neutral

STOCH(KDJ)(9,3,3)

56.059

Buy

ATR(14)

0.080

Low Volatility

CCI(14)

102.617

Buy

Williams %R

35.371

Buy

TRIX(12,20)

-0.119

Sell

StochRSI(14)

89.246

Buy

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

1.196

Buy

MA10

1.205

Buy

MA20

1.186

Buy

MA50

1.251

Sell

MA100

0.989

Buy

MA200

0.938

Buy

Institutional Confidence

Currency: USD Updated: 2025-09-19

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 13.92%, representing a quarter-over-quarter decrease of 3.69%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.00% of shares outstanding, with 100.00% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Ben-Noon (Dagi Shahar)

1.61M

+393.94%

Armistice Capital LLC

971.82K

Hayon (Joe)

628.54K

+0.29%

UBS Financial Services, Inc.

34.39K

HRT Financial LP

17.46K

Laidlaw Wealth Management LLC

13.50K

Equitable Holdings, Inc.

10.00K

Geode Capital Management, L.L.C.

2.92K

Risk Assessment

Currency: USD Updated: 2025-09-19

The company’s current risk assessment score is 3.09, which is lower than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 2.29. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.